相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pyronaridine: An update of its pharmacological activities and mechanisms of action
Christian Bailly
BIOPOLYMERS (2021)
Hepatic safety of repeated treatment with pyronaridine-artesunate versus artemether-lumefantrine in patients with uncomplicated malaria: a secondary analysis of the WANECAM 1 data from Bobo-Dioulasso, Burkina Faso
Yves Daniel Compaore et al.
MALARIA JOURNAL (2021)
Pyronaridine-artesunate real-world safety, tolerability, and effectiveness in malaria patients in 5 African countries: A single-arm, open-label, cohort event monitoring study
Gaston Tona Lutete et al.
PLOS MEDICINE (2021)
An in vitro toolbox to accelerate anti-malarial drug discovery and development
Susan A. Charman et al.
MALARIA JOURNAL (2020)
Effects of MAO-A and CYP450 on primaquine metabolism in healthy volunteers
Norliza Mat Ariffin et al.
PARASITOLOGY RESEARCH (2019)
Repurposing the antimalarial pyronaridine tetraphosphate to protect against Ebola virus infection
Thomas R. Lane et al.
PLOS NEGLECTED TROPICAL DISEASES (2019)
Superior Pyronaridine Single-Dose Pharmacodynamics Compared to Artesunate, Chloroquine, and Amodiaquine in a Murine Malaria Luciferase Model
Winter A. Okoth et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial
Issaka Sagara et al.
LANCET (2018)
Quantification of the antimalarial drug pyronaridine in whole blood using LC-MS/MS Increased sensitivity resulting from reduced non-specific binding
Daniel Blessborn et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2017)
Interactions between tafenoquine and artemisinin-combination therapy partner drug in asexual and sexual stage Plasmodium falciparum
Karen Kemirembe et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE (2017)
Nanodiamond mediated co-delivery of doxorubicin and malaridine to maximize synergistic anti-tumor effects on multi-drug resistant MCF-7/ADR cells
Hao Zhu et al.
JOURNAL OF MATERIALS CHEMISTRY B (2017)
Population Pharmacokinetics of Pyronaridine in Pediatric Malaria Patients
Amal Ayyoub et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Safety and efficacy of re-treatments with pyronaridine-artesunate in African patients with malaria: a substudy of the WANECAM randomised trial
Issaka Sagara et al.
LANCET INFECTIOUS DISEASES (2016)
Pharmacokinetic Interactions between Primaquine and Pyronaridine-Artesunate in Healthy Adult Thai Subjects
Podjanee Jittamala et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Mass balance and metabolism of the antimalarial pyronaridine in healthy volunteers
Carrie A. Morris et al.
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS (2015)
Pharmacokinetic Interaction between Pyronaridine-Artesunate and Metoprolol
Carrie A. Morris et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Delayed anemia assessment in patients treated with oral artemisinin derivatives for uncomplicated malaria: a pooled analysis of clinical trials data from Mali
Issaka Sagara et al.
MALARIA JOURNAL (2014)
Development of antimalarial drugs and their application in China: a historical review
Chang Chen
INFECTIOUS DISEASES OF POVERTY (2014)
Malarial pigment hemozoin and the innate inflammatory response
Martin Oliyier et al.
FRONTIERS IN IMMUNOLOGY (2014)
Insights into the Role of Heme in the Mechanism of Action of Antimalarials
Jill M. Combrinck et al.
ACS CHEMICAL BIOLOGY (2013)
The metabolism of primaquine to its active metabolite is dependent on CYP 2D6
Brandon S. Pybus et al.
MALARIA JOURNAL (2013)
Drug-Drug Interaction Analysis of Pyronaridine/Artesunate and Ritonavir in Healthy Volunteers
Carrie A. Morris et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2012)
Potential P-Glycoprotein-Mediated Drug-Drug Interactions of Antimalarial Agents in Caco-2 cells
Enoche F. Oga et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2012)
Pyronaridine-artesunate granules versus artemether-lumefantrine crushed tablets in children with Plasmodium falciparum malaria: a randomized controlled trial
Kassoum Kayentao et al.
MALARIA JOURNAL (2012)
Review of pyronaridine anti-malarial properties and product characteristics
Simon L. Croft et al.
MALARIA JOURNAL (2012)
Pyronaridine-Artesunate versus Mefloquine plus Artesunate for Malaria
Ronnatrai Rueangweerayut et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Absorption, Distribution, Excretion, and Pharmacokinetics of C-14-Pyronaridine Tetraphosphate in Male and Female Sprague-Dawley Rats
Sang Hyun Park et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2010)
A single LC-tandem mass spectrometry method for the simultaneous determination of 14 antimalarial drugs and their metabolites in human plasma
E. M. Hodel et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2009)
Population pharmacokinetics of artesunate and dihydroartemisinin following single- and multiple-dosing of oral artesunate in healthy subjects
Beesan Tan et al.
MALARIA JOURNAL (2009)
Anti-malarial efficacy of pyronaridine and artesunate in combination in vitro and in vivo
Livia Vivas et al.
ACTA TROPICA (2008)
Fixed-dose pyronaridine-artesunate combination for treatment of uncomplicated falciparum malaria in pediatric patients in Gabon
Michael Ramharter et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Development and validation of a liquid chromatography-mass spectrometry assay for the determination of pyronaridine in human blood for application to clinical pharmacokinetic studies
Himanshu Naik et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2007)
Antimalarial drugs inhibiting hemozoin (β-hematin) formation:: A mechanistic update
Sanjay Kumar et al.
LIFE SCIENCES (2007)
Epidemiology and burden of malaria in pregnancy
Meghna Desai et al.
LANCET INFECTIOUS DISEASES (2007)
Targeting of hematin by the antimalarial pyronaridine
Saranya Auparakkitanon et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
A new and simple solid-phase extraction method for LC determination of pyronaridine in human plasma
S Ramanathan et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2005)
In vitro and in vivo metabolism of pyronaridine characterized by low-energy collision-induced dissociation mass spectrometry with electrospray ionization
J Lee et al.
JOURNAL OF MASS SPECTROMETRY (2004)
Ion-trapping, microsomal binding, and unbound drug distribution in the hepatic retention of basic drugs
GA Siebert et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Antimalarial 9-anilinoacridine compounds directed at hematin
S Auparakkitanon et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Isoquine and related amodiaquine analogues: A new generation of improved 4-aminoquinoline antimalarials
PM O'Neill et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
Liquid chromatographic determination of pyronaridine in human plasma and oral dosage form
CP Babalola et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2003)
Determination of pyronaridine in whole blood by automated solid phase extraction and high-performance liquid chromatography
D Blessborn et al.
THERAPEUTIC DRUG MONITORING (2003)
Artemisinin and its derivatives - An important new class of antimalarial agents
GA Balint
PHARMACOLOGY & THERAPEUTICS (2001)
Improved assay method for the determination of pyronaridine in plasma and whole blood by high-performance liquid chromatography for application to clinical pharmacokinetic studies
YC Chen et al.
JOURNAL OF CHROMATOGRAPHY B (2001)
Cleavage of DNA induced by 9-anilinoacridine inhibitors of topoisomerase II in the malaria parasite Plasmodium falciparum
S Auparakkitanon et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
分享论文
